UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032063
Receipt number R000036576
Scientific Title A pharmacist-delivered smoking cessation program in community pharmacy: a cluster-randomized trial
Date of disclosure of the study information 2018/05/01
Last modified on 2022/04/05 09:42:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A pharmacist-delivered smoking cessation program in community pharmacy: a cluster-randomized trial

Acronym

FINE project (Family pharmacist's Intervention for Nicotine Elimination)

Scientific Title

A pharmacist-delivered smoking cessation program in community pharmacy: a cluster-randomized trial

Scientific Title:Acronym

FINE project (Family pharmacist's Intervention for Nicotine Elimination)

Region

Japan


Condition

Condition

Smokers

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the effect of the pharmacist-delivered smoking cessation program on smoking cessation in community pharmacies

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

Carbon Monoxide-verified Abstinence or Color reaction of YANIKEN-verified Abstinence [ Time Frame: Week 12]

Key secondary outcomes

1) Number of recommended cases to a smoking cessation clinic and visiting cases
2) Satisfaction score with pharmacist-delivered smoking cessation program
3) Recommendation score with pharmacist-delivered smoking cessation program


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration


Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

1) Setting the target goal
2) Assessment and counseling for smoking cessation along with medication counseling
3) Telephone-delivered counseling
4) Giving information using support materials
5) Explanation and medication counseling of smoking cessation aids

Interventions/Control_2

Usual care by pharmacist

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Person who taking medications
2) Person who are expected to visit community pharmacy over 8 weeks
3) Person who agree to receive smoking cessation program

Key exclusion criteria

1) Dementia or psychiatric disorders
2) Allergies or adverse effects with smoking cessation aids
3) Temporomandibular Joint Disorder (in the case of nicotine gum)
4) Pregnant women

Target sample size

84


Research contact person

Name of lead principal investigator

1st name Mitsuko
Middle name
Last name Onda

Organization

Osaka University of Pharmaceutical Sciences

Division name

Department of Social and Administrative Pharmacy

Zip code

569-1041

Address

4-20-1 Nasahara, Takatsuki, Osaka

TEL

+81-72-690-1059

Email

onda@gly.oups.ac.jp


Public contact

Name of contact person

1st name Mitsuko
Middle name
Last name Onda

Organization

Osaka University of Pharmaceutical Sciences

Division name

Department of Social and Administrative Pharmacy

Zip code

569-1041

Address

4-20-1 Nasahara, Takatsuki, Osaka

TEL

+81-72-690-1059

Homepage URL


Email

onda@gly.oups.ac.jp


Sponsor or person

Institute

Osaka University of Pharmaceutical Sciences

Institute

Department

Personal name



Funding Source

Organization

Osaka University of Pharmaceutical Sciences

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka University of Pharmaceutical Sciences

Address

4-20-1, Nasahara, Takatsuki, Osaka, Japan

Tel

+81-72-690-1103

Email

kenkyus@gly.oups.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 05 Month 01 Day


Related information

URL releasing protocol

A pharmacist-delivered smoking cessation program in community pharmacy: a cluster-randomized trial

Publication of results

Unpublished


Result

URL related to results and publications

https://doi.org/10.1155/2021/9983515

Number of participants that the trial has enrolled

24

Results

572 smokers who met the eligibility criteria visited the target pharmacies. Of these, 24 patients agreed to participate in the study. Smoking cessation rates were 45.5% in the intervention group and 18.2% in the control group (P = 0:380, effect size = 0:60).

Results date posted

2022 Year 04 Month 05 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Smokers aged 20 years or older who receive prescription medicines at pharmacies participating in the study and who are able to visit the pharmacy for a continuous period of three months

Participant flow

After receiving an explanation about the study from the pharmacist and agreeing to participate, participants received smoking cessation support through the FINE programme in the intervention group and usual support in the control group

Adverse events

No adverse events occurred during the study period.

Outcome measures

The primary endpoint was participants who had quit smoking at the end of the 3-month follow-up period (3-month quit rate).

Plan to share IPD

No data sharing plan for individual cases

IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2018 Year 03 Month 30 Day

Date of IRB

2018 Year 03 Month 30 Day

Anticipated trial start date

2018 Year 04 Month 15 Day

Last follow-up date

2019 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 04 Month 02 Day

Last modified on

2022 Year 04 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036576


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name